Drug for further processing · DRUG FOR FURTHER PROCESSING
Mirtazapine NDC 65862-021
Mirtazapine 15 mg/1 · Tablet, Orally disintegrating · Aurobindo Pharma Limited
Unfinished product
This listing is a drug for further processing, not a finished drug product dispensed or administered to patients. It is not normally billed.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65862-021-81 | 65862002181 | 8000 TABLET, ORALLY DISINTEGRATING in 1 BAG (65862-021-81)Marketed from 08-DEC-05 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Generic name (nonproprietary)
- mirtazapine
- Active ingredients
- Mirtazapine — 15 mg/1
- Dosage form
- Tablet, Orally disintegrating
- Labeler
- Aurobindo Pharma Limited
- Product type
- Drug for further processing
- Marketing category
- Drug for further processing
- Marketing start
- Listing expires
- Identifiers
- Product ID 65862-021_1b9960f0-33df-49da-a9c5-3bb6f7897bdcSPL ID 1b9960f0-33df-49da-a9c5-3bb6f7897bdc
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N465862002181followed by a unit qualifier and the quantityPackage 65862-0021-81. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.